Measurement of Some non-routine Markers in Patients with Chronic Kidney Disease

Authors

  • Haider Ali Laibi
  • Abdulkareem M. Jawad

DOI:

https://doi.org/10.37506/ijfmt.v15i4.16880

Keywords:

CKD , soluble alpha klotho proteins , irisin , cystatin C

Abstract

Chronic kidney disease has an indirect effect on global disorder and death by raising the risks of morbidity
and mortality . This study included (60) patient diagnosed chronic renal failure; it also included (25)
healthy subjects as control . In study population age ranged from (14-65 years) old who visited Al-Basrah
Teaching Hospital in Basrah throughout the period from October 2020 to February 2021. Enzyme-Linked
Immunosorbent Assay (ELISA) was used to measure human serum soluble alpha klotho proteins , irisin and
cystatin C . The results showed that there is a high significant difference (P value < 0.01) in the levels between
CKD patients and control for the following : Soluble-a-klotho protein; Irisin (ng/ml) ; Cystatin-C (ng/ml).
There was also a high significant decrease in the levels of irisin (ng/ml)among different stages of chronic
kidney . The same table revealed a high significant increase (P value <0.01) in the levels of Cystatin-C (ng/
ml) and Soluble-a-klotho protein (ng/ml) among different stages of chronic kidney and respectively) . The
study concluded that there is a remarkable decrease in the level of serum soluble alpha klotho proteins and
irisin and increase in serum cystatin C in patients with chronic kidney disease ; and these differences are
positively correlated with the glomerular filtration rate .

Author Biographies

Haider Ali Laibi

Research Scholar, Medical and Health Technical College, Southern Technical University,Iraq

Abdulkareem M. Jawad

Assistant Professor, Medical and Health Technical College, Southern Technical University,Iraq

Published

2021-08-16

How to Cite

Haider Ali Laibi, & Abdulkareem M. Jawad. (2021). Measurement of Some non-routine Markers in Patients with Chronic Kidney Disease. Indian Journal of Forensic Medicine & Toxicology, 15(4), 1252-1256. https://doi.org/10.37506/ijfmt.v15i4.16880